Metabolic and inflammatory responses to trauma and infection

Fischer's Mastery of Surgery: Sixth Edition

Volumn 1, Issue , 2012, Pages

  Abumrad, Naji N ^a   Breitman, Igal ^a   Wattacheril, Julia ^b   Hubbard, William J ^c   Chaudry, Irshad H ^d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Columbia University School of Medicine ^*  (United States)

^c UNIVERSITY OF ALABAMA   (United States)

^d UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84973428789     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (89)

1. Agnese DM, Calvano JE, Hahm SJ, et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 2002;186:1522-5.
2. Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000;192:565-70.
3. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.
4. Ayala A, Meldrum DR, Perrin MM, Chaudry IH. The release of transforming growth factor-beta following haemorrhage: its role as a mediator of host immunosuppression. Immunology 1993;79:479-84.
5. Barnes PJ, Karin M. Nuclear factor-kappa-B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71.
6. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985;229(4716):869-71.
7. Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81:1-5.
8. Boeuf B, Poirier V, Gauvin F, et al. Naloxone for shock. Cochrane Database Syst Rev 2003 (Issue 4), CD004443.
9. Cai B, Chen F, Ji Y, et al. Alpha7 cholinergic-agonist prevents systemic inflammation and improves survival during resuscitation. J Cell Mol Med 2009;13(9B):3774-3785.
10. Cruickshank AM, Fraser WD, Burns HJ, et al. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci 1990;79:161-5.
11. Cruickshank AM, Fraser WD, Burns HJ, et al. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci 1990;79(2):161-5.
12. Cuthbertson D, Tinstone WT. Metabolism during the postinjury period. Adv Clin Chem 1969; 12:1-55.
13. Cuthbertson DP. Observations on the disturbances of metabolism produced by injury to the limbs. Quart J Med 1932;1:233-44.
14. Czermak BJ, Sarma V, Pierson CL, et al. Protective effects of C5a blockade in sepsis. Nat Med 1999;5:788-92.
15. de Diego AMG, Gandía L, García AG. A physiological view of the central and peripheral mechanisms that regulate the release of catecholamines at the adrenal medulla. Acta Physiol 2008;192:287-301.
16. de Jonge WJ, van der Zanden EP, The FO, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005;6(8):844-51. Epub 2005 July 17. Erratum in: Nat Immunol2005;6(9):954.
17. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73.
18. Dietz A, Heimlich F, Daniel V, et al. Immunomodulating effects of surgical intervention in tumors of the head and neck. Otolaryngol Head Neck Surg 2000;123:132-9.
19. Dünser W, Walter R. Hasibeder. Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress Martin. J Intensive Care Med 2009;24(5): 293-316.
20. Dunne A, O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003;2003:re3.
21. Fliers E, Guldenaar SF, Wiersinga WM, et al. Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with non-thyroidal illness. J Clin Endocrinol Metab 1997;82:4032-6.
22. Glaser F, Sannwald GA, Buhr HJ, et al. General stress response to conventional and laparoscopic cholecystectomy. Ann Surg 1995;221:372-80.
23. Goehler LE, Relton JK, Dripps D, et al. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res Bull 1997;43(3):357-64.
24. Guarini S, Altavilla D, Cainazzo MM, et al. Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation 2003;107(8):1189-94.
25. Hendrik S, Dirk H, Joachim W, et al. The Alteration of Autonomic Function in Multiple Organ Dysfunction Syndrome. Crit Care Clin 2008; 24:149-63.
26. Hildebrandt U, Kessler K, Pistorius G, et al. Granulocyte elastase and systemic cytokine response after laparoscopic-assisted and open resections in Crohn's disease. Dis Colon Rectum 1999;42:1480-6.
27. Hildebrandt U, Kessler K, Plusczyk T, et al. Comparison of surgical stress between laparoscopic and open colonic resections. Surg Endosc 2003;17:242-6.
28. Höllt V. Opioid peptide processing and receptor selectivity. Annu Rev Pharmacol Toxicol 1986;26:59-77.
29. Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat Immunol 2004;5(10):971-4.
30. Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999;162:3749-52.
31. Huber-Lang M, Sarma VJ, Lu KT, et al. Role of C5a in multiorgan failure during sepsis. J Immunol 2001;166:1193-9.
32. Huston JM, Gallowitsch-Puerta M, Ochani M, et al. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007;35(12):2762-8.
33. Jamieson T, Cook DN, Nibbs RJ, et al. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol 2005;6:403-11.
34. Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002;347:185Y192.
35. Klava A, Windsor AC, Farmery SM, et al. Interleukin-10. A role in the development of postoperative immunosuppression. Arch Surg 1997; 132:425-9.
36. Kloosterman T, von Blomberg BM, Borgstein P, et al. Unimpaired immune functions after laparoscopic cholecystectomy. Surgery 1994; 115:424-8.
37. Labuz D, Berger S, Mousa SA, et al. Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain. J Neurosci 2006;26:4350-58.
38. Lamberts SW, Bruining HA, de Jong FH. Corticosteroid therapy in severe illness. N Engl J Med 1997;337:1285-92.
39. Lorenz E, Mira JP, Frees KL, et al. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002;162:1028-32.
40. Luce JM. Physicians should administer low-dose corticosteroids selectively to septic patients until an ongoing trial is completed. Ann Intern Med 2004;141:70-2.
41. Maier SF, Goehler LE, Fleshner M, et al. The role of the vagus nerve in cytokine-to-brain communication. Ann N Y Acad Sci 1998;840:289-300.
42. Maldonado LS, Murata GH, Hershman JM, et al. Do thyroid function tests independently predict survival in the critically ill? Thyroid 1992;2:119-23.
43. Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 2006;6:907-18.
44. Marik PE, Zaloga GP. Critical care review Adrenal Insufficiency in the critically ill: a new look at an old problem. Chest 2002;122:1784-96.
45. Martinez T, Buracchi C, Borroni EM, et al. Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci USA 2007;104:2319-24.
46. Martinez T, Locati M, Buracchi C, et al. Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur J Immunol 2005;35:1342-6.
47. Meakins JL, Pietsch JB, Bubenick O, et al. Delayed hypersensitivity: indicator of acquired failure of host defences in sepsis and trauma. Ann Surg 1977;186:241-50.
48. Michalaki M, Vagenakis A, Makri M, et al. Dissociation of the early decline in serum T3 concentration and serum IL-6 rise and TNFα in nonthyroidal illness syndrome induced by abdominal surgery. J Clin Endocrinol Metab 2001;86:4198-205.
49. Molina PE, Abumrad NN. Differential effects of hemorrhage and LPS on tissue TNF, IL-1 and associated neurohormonal and opioid alterations. Life Sci 2000;66:399-409.
50. Molina PE. Stress-specific opioid modulation of haemodynamic counter-regulation. Clin Exp Pharmacol Physiol 2002;29:248-53.
51. Moore FD, Olsen KH, McMurry JD. The body cell mass and its supporting environment. Philadelphia: WB Saunders; 1978.
52. Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 2003;284:L566-77.
53. Naito Y, Fukata J, Tamai S, et al. Biphasic changes in hypothalamic-pituitary-adrenal function during the early recovery period after major abdominal surgery. J Clin Endocrinol Metab 1991;73:111-7.
54. Naito Y, Tamai S, Shingu K, et al. Responses of plasma adrenocorticotropic hormone, cortisol, and cytokines during and after upper abdominal surgery. Anesthesiology 1992;77:426-31.
55. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 2005;17:359-65.
56. Parrish WR, Rosas-Ballina M, Gallowitsch-Puerta M, et al. Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med 2008;14(9-10):567-74.
57. Pavlov VA, Ochani M, Yang LH, et al. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med 2007;35(4):1139-44.
58. Riedemann NC, Neff TA, Guo RF, et al. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol 2003;170:503-7.
59. Rittner HL, Brack A, Stein C. Pain and the immune system. Br J Anaesth 2008;101:40-4.
60. Rivkind AI, Siegel JH, Lettleton M, et al. Neutrophil oxidative burst activation and the pattern of respiratory physiologic abnormalities in the fulminant post-traumatic adult respiratory distress syndrome. Circ Shock 1991;33:48-62.
61. Robert C, Kupper TS. Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 1999;341(24):1817-28.
62. Rogers TJ, Peterson PK. Opioid G protein-coupled receptors: Signals at the crossroads of inflammation. Trends Immunol 2003;24:116-21.
63. Rot A. Contribution of Duffy antigen to chemokine function. Cytokine Growth Factor Rev 2005; 16:687-94.
64. Rouhiainen A, Kuja-Panula J, Wilkman E, et al. Regulation of monocyte migration by amphoterin (HMGB1). Blood 2004;104:1174-82.
65. Sakharova OV, Inzucchi SE. Endocrine assessments during critical illness. Crit Care Clin 2007; 23:467-90.
66. Salomon F, Cuneo RC, Hesp R, et al. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321:1797-803.
67. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-5.
68. Schmidt H, Müller-Werdan U, Hoffmann T, et al. Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med 2005;33(9):1994-2002.
69. Schmidt H, Werdan K, Müller-Werdan U. Autonomic dysfunction in the ICU patient. Curr Opin Crit Care 2001;7(5):314-22.
70. Schwandner R, Dziarski R, Wesche H, et al. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999;274:17406-9.
71. Shatney CH, Benner C. Sequential serum complement (C3) and immunoglobulin levels in shock/trauma patients developing acute fulminant systemic sepsis. Circ Shock 1985;16:9-17.
72. Slag MF, Morley JE, Elson MK, et al. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 1981;245:43-5.
73. Stein C, Schafer M, Machelska H. Attacking pain at its source: new perspectives on opioids. Nat Med 2003;9:1003-8
74. Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999;341:785-92.
75. Taylor BE, Buchman TG. Is there a role for growth hormone therapy in refractory critical illness? Curr Opin Crit Care 2008;14(4):438-44.
76. The FO, Boeckxstaens GE, Snoek SA, et al. Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice. Gastroenterology 2007;133(4):1219-28.
77. Tilg H, Trehu E, Atkins MB, et al. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994;83:113-8.
78. Turnbull AV, Rivier CL. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev 1999;79:1-71.
79. Ueo H, Honda M, Adachi M, et al. Minimal increase in serum interleukin- 6 levels during laparoscopic cholecystectomy. Am J Surg 1994; 168:358-60.
80. Ulloa L, Ochani M, Yang H, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 2002;99:12351-6.
81. van Westerloo DJ, Giebelen IA, Florquin S, et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 2006;130(6):1822-30.
82. Venet F, Bohe J, Debard AL, et al. Both percentage of gammadelta. T lymphocytes and CD3 expression are reduced during septic shock. Crit Care Med 2005;33:2836-40.
83. Vermes I, Beishuizen A, Hampsink RM, et al. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 1995; 80:1238-42.
84. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-51.
85. Wang H, Liao H, Ochani M, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10(11):1216-21.
86. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003;421(6921):384-8.
87. Wurfel MM, Gordon AC, Holden TD, et al. Toll-like Receptor 1 Polymorphisms Affect Innate Immune Responses and Outcomes in Sepsis. Am J Respir Crit Care Med 2008;178:710-20.
88. Wurtman RJ. Stress and the adrenocortical control of epinephrine synthesis. Metabolism 2002;51(6, Suppl 1):11-14.
89. Yang H, Ochani M, Li J, et al. Reversing established sepsis with antagonists of endogenous high mobility group box 1. Proc Natl Acad Sci USA 2004;101:296-301.